Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity
- PMID: 17668247
- DOI: 10.1007/s00467-007-0529-8
Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity
Abstract
Nephropathic cystinosis is a lysosomal storage disorder, which, if untreated, results in renal failure by age 10 years. Oral cysteamine has been shown to preserve renal function in these patients. In this study, a 2-year-old girl with nephropathic cystinosis and severe gastrointestinal dysmotility was treated with intravenous (i.v.) administration of cysteamine hydrochloride (HCl). This is only the second report of long-term i.v. cysteamine therapy for nephropathic cystinosis. Unlike the treatment in the previous case, however, treatment in our patient was limited by liver toxicity.
Similar articles
-
Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.Kidney Int. 2012 Jan;81(2):179-89. doi: 10.1038/ki.2011.277. Epub 2011 Sep 7. Kidney Int. 2012. PMID: 21900880
-
Intravenous cysteamine therapy for nephropathic cystinosis.Pediatr Res. 1995 Oct;38(4):579-84. doi: 10.1203/00006450-199510000-00018. Pediatr Res. 1995. PMID: 8559613
-
Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.Pediatr Transplant. 2016 Feb;20(1):141-5. doi: 10.1111/petr.12617. Epub 2015 Oct 19. Pediatr Transplant. 2016. PMID: 26477696
-
Early oral cysteamine therapy for nephropathic cystinosis.Eur J Pediatr. 2003 Dec;162 Suppl 1:S38-41. doi: 10.1007/s00431-003-1349-x. Epub 2003 Nov 11. Eur J Pediatr. 2003. PMID: 14610675 Review.
-
[Cystinosis in adults: A systemic disease].Nephrol Ther. 2015 Jun;11(3):152-9. doi: 10.1016/j.nephro.2014.12.001. Epub 2015 Mar 11. Nephrol Ther. 2015. PMID: 25769364 Review. French.
Cited by
-
In vitro activity of cysteamine against SARS-CoV-2 variants.Mol Genet Metab. 2022 Sep-Oct;137(1-2):192-200. doi: 10.1016/j.ymgme.2022.08.009. Epub 2022 Sep 5. Mol Genet Metab. 2022. PMID: 36115282 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical